{
  "id": "82a46b3d716b837a",
  "title": "STAT+: Merck suffers a setback over its new Keytruda formulation in Germany",
  "description": "In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new subcutaneous formulation of Keytruda in Germany. The ruling came as&#8230;",
  "content": "In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new subcutaneous formulation of Keytruda in Germany. The ruling came as&#8230;",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2025/12/04/merck-keytruda-patent-halozyme-germany-europe-united-states/?utm_campaign=rss",
  "published_at": "2025-12-04T23:58:30+00:00",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Merck suffers a setback over its new Keytruda formulation in Germany",
    "description": "In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new subcutaneous formulation of Keytruda in Germany. The ruling came as&#8230;",
    "url": "https://www.statnews.com/pharmalot/2025/12/04/merck-keytruda-patent-halozyme-germany-europe-united-states/?utm_campaign=rss",
    "published": "2025-12-04T23:58:30+00:00",
    "source": "STAT"
  }
}